[NON-ARTHROPLASTY TREATMENT FOR KNEE OSTEOARTHRITIS].

Autor: Stahl I; Orthopedic Surgery Division - Rambam Health Care Campus., Ginesin E; Orthopedic Surgery Division - Rambam Health Care Campus., Hous N; Orthopedic Surgery Division - Rambam Health Care Campus., Kotlyarsky P; Orthopedic Surgery Division - Rambam Health Care Campus., Norman D; Orthopedic Surgery Division - Rambam Health Care Campus., Peskin B; Orthopedic Surgery Division - Rambam Health Care Campus.
Jazyk: hebrejština
Zdroj: Harefuah [Harefuah] 2017 Jul; Vol. 156 (7), pp. 455-459.
Abstrakt: Introduction: Osteoarthritis is characterized by marked pain, stiffness and reduced range of motion and is one of the most common causes of disability and reduced quality of life. The disease is diagnosed in 20% of the adult population; the prevalence rises to 50% of adults over 65 years of age. There are various treatment options in the early stages of knee osteoarthritis which are intended to postpone the need for arthroplasty, which is the gold standard treatment at the end-stage level of the disease. Evidence based medicine (EBM) facilitates optimized decision-making and treatment for an individual patient based on meta-analysis, randomize control studies and systematic reviews. Based on these studies, physical activity is an effective treatment option resulting in reduced disability and improved quality of life. Among other conservative treatment options, chondroitin, a food supplement, was found to be as effective as anti-inflammatory medication with a lower side effect profile. Similar results were found for intra-articular injections of hyaluronic acid, while intra-articular injections of platelet rich plasma (PRP) were found to be the most effective of all the above. No advantage was reported for knee arthroscopy over conservative treatment options even when examining those patients with combined symptomatic meniscal tear and knee osteoarthritis. Non-steroidal anti-inflammatory medication (NSAIDS) and opiate treatment have limited long term effect on reducing pain, disability and improving quality of life. These drugs can have a high rate of substantial side effect. Hence, their use should be limited, especially in the elderly population, and safer modalities should be explored.
Databáze: MEDLINE